- Share Prices
Nuformix PLC (NFX)
0.42p-0.01 (-2.35%)05 Nov 2025, 09:45
Nuformix PLC Market & Company News
| 28.10.2025 07:00 | NFX | Underwritten Open Offer | RNS |
| 10.10.2025 07:00 | NFX | Change of Auditor | RNS |
| 25.09.2025 07:00 | NFX | European Respiratory Society Congress Attendance | Reach |
| 11.08.2025 12:11 | NFX | IN BRIEF: Nuformix submits FDA drug designation application for NXP002 | Alliance |
| 11.08.2025 07:00 | NFX | US FDA ODD Application Submitted for NXP002 | RNS |
| 30.05.2025 14:24 | NFX | Total Voting Rights | RNS |
| 29.05.2025 18:21 | NFX | Nuformix shares fall despite EU orphan drug status for lead treatment | Alliance |
| 29.05.2025 07:00 | NFX | Confirmation of European ODD for NXP002 | RNS |
| 23.05.2025 13:08 | NFX | Publication of a Prospectus | RNS |
| 22.05.2025 07:00 | NFX | £210,000 Placing | RNS |
| 19.05.2025 07:00 | NFX | Attendance at American Thoracic Society Congress | Reach |
| 02.05.2025 12:19 | NFX | Nuformix interim loss widens as focused on advancing assets | Alliance |
| 02.05.2025 07:00 | NFX | Half-year Report | RNS |
| 30.04.2025 07:00 | NFX | Confirmation of European Orphan Drug Designation | RNS |
| 29.04.2025 07:00 | NFX | Change of Registered Office and Company Secretary | RNS |
| 14.04.2025 12:22 | NFX | Correction - Exercise of Warrants | RNS |
| 14.04.2025 07:00 | NFX | Exercise of Warrants | RNS |
| 09.04.2025 16:29 | NFX | Nuformix finds positive data for NXP002 in lung fibrosis study | Alliance |
| 09.04.2025 07:00 | NFX | NXP002 Update | RNS |
| 20.03.2025 11:10 | NFX | Result of AGM | RNS |
| 13.03.2025 14:41 | VIP, SUPR, NFX | UK shareholder meetings calendar - next 7 days | Alliance |
| 28.02.2025 12:30 | NFX | Total Voting Rights | RNS |
| 14.02.2025 14:18 | NFX | Posting of Annual Report and Notice of AGM | RNS |
| 30.01.2025 07:00 | NFX | £168,750 Placing | RNS |
| 29.01.2025 15:48 | NFX, ASIA, PGH | EARNINGS AND TRADING: S-Ventures loss narrows; charge knocks Nuformix | Alliance |
| 29.01.2025 07:00 | NFX | Annual Results for period ended 30 September 2024 | RNS |
| 28.01.2025 07:00 | NFX | NXP002 ODD Application Submitted | RNS |
| 13.01.2025 12:50 | NFX, MKA, COBR | TRADING UPDATES: Eden Research in revenue rise; Cordel gets UK deal | Alliance |
| 13.01.2025 07:00 | NFX | NXP002 Orphan Drug Designation Draft Application | RNS |
| 29.11.2024 17:00 | NFX | Total Voting Rights | RNS |
| 05.11.2024 14:25 | NFX | Director/PDMR Dealings | RNS |
| 04.11.2024 10:17 | NFX | Result of General Meeting | RNS |
| 28.10.2024 12:27 | NFX, BASC | UK shareholder meetings calendar - next 7 days | Alliance |
| 16.10.2024 13:37 | NFX | Publication of Prospectus & Notice of GM | RNS |
| 20.09.2024 14:24 | NFX | £300,000 Fundraise | RNS |
